Article Details

Navidea Biopharmaceuticals Announces Submission of Formal Type B Meeting Request with FDA ...

Retrieved on: 2021-02-08 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Navidea Biopharmaceuticals Announces Submission of Formal Type B Meeting Request with FDA .... View article details on hiswai:

Excerpt

DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up